Rising prevalence of chronic and infectious diseases globally has led to the rise in cell viability assays market value. Data Bridge Market Research analyses that the cell viability assays market will exhibit a CAGR of around 7.34% for the forecast period of 2021-2028.
Cell viability assays are a technology that is used to determine the overall health of cells and further measure the cell survival characteristics. It is a homogeneous method that is used to detect the number of dead or living cells in a sample regardless of the phase around the cell cycle. In other words, cell viability assays are an assessment of organ ability, cells, or tissues to improve viability. Cell viability assay is calculated using the ratio of total live/total cells. The increase in cell viability indicates cell growth while a decrease in cell viability indicates toxic effects of the compound.
The growing prevalence of chronic disorders and infectious diseases will propel the growth in the demand for cell viability assays. Rising expenditure to develop healthcare infrastructure coupled with rising research and development proficiencies to make advancements in the technology has fuelled up the demand for cell viability assays. The rising geriatric population coupled with changing lifestyles are some other indirect cell viability assays market growth determinants.
However, the lack of professionals and technical experts to run these instruments will challenge the growth of the cell viability assays market in the forecast period mentioned above. Also, the high cost of instruments will obstruct the market growth rate.
This cell viability assays market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on cell viability assays market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Cell Viability Assays Market Scope and Market Size
The cell viability assays market is segmented on the basis of applications, products, cell type and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of applications, the cell viability assays market is segmented into stem cell research, clinical and diagnostics applications, drug discovery and development, basic research and other applications.
- Based on products, the cell viability assays market is segmented into consumables and instruments. Consumables have been further segmented into reagents, assay kits and micro plates. Assay kits have been further sub segmented into tetrazolium reduction assay kits, reassuring cell viability assays kits, calcien- AM cell viability assays kits and other assay kits. Instruments have been further segmented into automated cell counters have been further segmented into flow cytometers, spectrophotometers, cell imaging and analysis systems.
- Based on cell type, the cell viability assays market is segmented into human cells, microbial cells and animal cells.
- The cell viability assays market is also segmented on the basis of end users into pharmaceutical & biotechnology companies, academic and research institutes, hospital and diagnostics laboratories and other end users.
Cell Viability Assays Market Country Level Analysis
The cell viability assays market is analysed and market size insights and trends are provided by applications, products, cell type and end users as referenced above.
The countries covered in the cell viability assays market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell viability assays market owing to the prevalence of supportive insurance coverage policies coupled with prevalence of structured distribution channels. Prevalence of sophisticated technological healthcare facilities will also drive the market growth in this region. Asia-Pacific on the other hand will score the highest growth rate during the forecast period owing to rising incidences of chronic disorders and infectious diseases.
The country section of the cell viability assays market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Cell Viability Assays Market Share Analysis
The surgical site infection control market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to surgical site infection control market.
The major players covered in the surgical site infection control market report are Corning Incorporated, Thermo Fisher Scientific Inc., Merck KGaA, Bio-Rad Laboratories, Inc., General Electric, Danaher, BD, QIAGEN, Promega Corporation., Agilent Technologies, Inc., Biotium, Abcam plc, BioTek Instruments, Inc., PerkinElmer Inc., Pfizer Inc., Creative Bioarray, Geno Technology Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, GlaxoSmithKline plc.and Gilead Sciences, Inc. among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.